KR101684457B1 - Feed supplement for reducing cholesterol content which contains persimmon - Google Patents
Feed supplement for reducing cholesterol content which contains persimmon Download PDFInfo
- Publication number
- KR101684457B1 KR101684457B1 KR1020150163278A KR20150163278A KR101684457B1 KR 101684457 B1 KR101684457 B1 KR 101684457B1 KR 1020150163278 A KR1020150163278 A KR 1020150163278A KR 20150163278 A KR20150163278 A KR 20150163278A KR 101684457 B1 KR101684457 B1 KR 101684457B1
- Authority
- KR
- South Korea
- Prior art keywords
- feed
- cholesterol
- acid
- content
- fatty acid
- Prior art date
Links
- 235000011511 Diospyros Nutrition 0.000 title claims abstract description 18
- 244000236655 Diospyros kaki Species 0.000 title claims abstract description 17
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract description 76
- 235000012000 cholesterol Nutrition 0.000 title abstract description 34
- 239000006052 feed supplement Substances 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 20
- 239000003674 animal food additive Substances 0.000 claims abstract description 14
- 229910052604 silicate mineral Inorganic materials 0.000 claims abstract description 12
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000013372 meat Nutrition 0.000 abstract description 23
- 235000013305 food Nutrition 0.000 abstract description 21
- 241001465754 Metazoa Species 0.000 abstract description 18
- 230000000052 comparative effect Effects 0.000 description 40
- 229910052500 inorganic mineral Inorganic materials 0.000 description 19
- 239000011707 mineral Substances 0.000 description 19
- 238000011282 treatment Methods 0.000 description 19
- 238000000034 method Methods 0.000 description 18
- 235000015277 pork Nutrition 0.000 description 15
- 150000004671 saturated fatty acids Chemical class 0.000 description 15
- 238000012360 testing method Methods 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 11
- 244000144972 livestock Species 0.000 description 11
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 11
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 11
- 230000001953 sensory effect Effects 0.000 description 10
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000004020 conductor Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 7
- 229940012843 omega-3 fatty acid Drugs 0.000 description 7
- 235000019786 weight gain Nutrition 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 6
- 229940033080 omega-6 fatty acid Drugs 0.000 description 6
- 241000282898 Sus scrofa Species 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 235000021050 feed intake Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 235000003441 saturated fatty acids Nutrition 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- 108010023302 HDL Cholesterol Proteins 0.000 description 4
- 208000035150 Hypercholesterolemia Diseases 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 241000282887 Suidae Species 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 235000019750 Crude protein Nutrition 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108010028554 LDL Cholesterol Proteins 0.000 description 3
- 238000008214 LDL Cholesterol Methods 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 235000019784 crude fat Nutrition 0.000 description 3
- 235000021051 daily weight gain Nutrition 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229960002733 gamolenic acid Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 3
- 238000003307 slaughter Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- 235000019737 Animal fat Nutrition 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 102100031478 C-type natriuretic peptide Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 101000796277 Homo sapiens C-type natriuretic peptide Proteins 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000010903 husk Substances 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- NAIXASFEPQPICN-UHFFFAOYSA-O p-nitrophenylphosphocholine Chemical compound C[N+](C)(C)CCOP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 NAIXASFEPQPICN-UHFFFAOYSA-O 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- XSXIVVZCUAHUJO-AVQMFFATSA-N (11e,14e)-icosa-11,14-dienoic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-AVQMFFATSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- YEBDWAHEIMUJQT-ZLCLUPBPSA-N (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O.CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YEBDWAHEIMUJQT-ZLCLUPBPSA-N 0.000 description 1
- AQQWWUIGQFJCMJ-OQQRQXPPSA-N (9z,12z,15z)-octadeca-9,12,15-trienoic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O.CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O AQQWWUIGQFJCMJ-OQQRQXPPSA-N 0.000 description 1
- -1 (pottery) pottery Substances 0.000 description 1
- YZAZXIUFBCPZGB-QZOPMXJLSA-N (z)-octadec-9-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O YZAZXIUFBCPZGB-QZOPMXJLSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000723267 Diospyros Species 0.000 description 1
- 235000021297 Eicosadienoic acid Nutrition 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000021322 Vaccenic acid Nutrition 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000019742 Vitamins premix Nutrition 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000008242 dietary patterns Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- WLGSIWNFEGRXDF-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O.CCCCCCCCCCCC(O)=O WLGSIWNFEGRXDF-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 229940108623 eicosenoic acid Drugs 0.000 description 1
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000010433 feldspar Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000021299 gondoic acid Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KYYWBEYKBLQSFW-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O KYYWBEYKBLQSFW-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000019462 natural additive Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Abstract
Description
The present invention relates to a method of producing low cholesterol meat and low cholesterol meat produced by the method and a livestock feed additive therefor. In particular, the present invention relates to a method of lowering the cholesterol level of a livestock by feeding a feed additive having cholesterol-lowering effect to a livestock feed, and an animal food of low cholesterol such as meat obtained from the produced low-cholesterol livestock.
Cholesterol is a type of fat present in all animal foods and is a component of cells and an essential component of hormone synthesis. Proper cholesterol plays an important role in maintaining good health. However, because too much cholesterol adversely affects the human body, proper cholesterol maintenance is very important to health. Hypercholesterolemia is a common chronic condition that can be found in 52% of the world's adult population. Hypercholesterolemia is a direct cause of atherosclerosis, and ultimately hypertension, angina pectoris, , Myocardial infarction, stroke, and the like. According to statistics of the 1900s, heart disease was the fourth cause of death following pneumonia, influenza, tuberculosis, diarrhea and enteritis, accounting for only 8% of all deaths, but it has emerged as the first death cause of mankind in modern times.
This is thought to be due to an increase in patients with hypercholesterolemia due to changes in dietary habits such as increased intake of animal foods. Therefore, the efforts to lower the blood cholesterol level are not only for the purpose of treatment but also for the prevention of adult diseases, and the related research efforts have been actively conducted worldwide.
Cholesterol in the body is synthesized in the body or is a result of food intake from the outside. Thus, blood cholesterol is mainly determined by the amount of synthesis in the body and the amount of food taken from the food. The amount of the body's synthesis is almost constant, but the intake from the food is not constant due to various environmental factors such as the dietary pattern. In other words, the cause of hypercholesterolemia is largely genetic and environmental factors. High cholesterol due to environmental factors is mainly caused by egg products, meat products, dairy products (milk, butter) An excessive intake of animal fat is thought to be the main reason. However, the intake of animal food is increasing every year. Especially, as the economy develops, the consumption of animal food is increasing, and it is thought to be practically impossible to dramatically reduce the consumption of animal food. In addition, the intake of animal foods is essential for prevention of osteoporosis and protein intake. Recently, studies on lowering the cholesterol content of animal foods have been carried out in various ways rather than efforts to reduce consumption of animal food itself.
As a method of lowering the cholesterol content of an animal food, there is a method of extracting and removing cholesterol from a fat-soluble solvent in the processing step. This method is effective for decreasing cholesterol content, but it has a limitation in that the process is complicated and can be applied only to processed foods. Therefore, in order to lower the cholesterol level contained in naturally obtained animal foods, it should be approached in terms of breeding improvement methods and livestock feed.
In breeding improvement methods, low cholesterol livestock having low cholesterol content is obtained by biotechnology or breeding method, and methods for obtaining low cholesterol animal food from the livestock have been tried. This method is difficult and time consuming in the method There are no successful cases of cholesterol-lowering effects reported so far.
Next, many methods of producing low-cholesterol animal food by feeding low-fat high-fiber feed or natural additives known to have a cholesterol-lowering effect to livestock have been tried. However, the method that has been attempted so far has proved to be very difficult to be practically used for the production of low cholesterol animal foods because the cholesterol-lowering effect of livestock is too small. In addition, no feed additive has been found which can produce animal foods with low cholesterol, while maintaining good meat quality of meat.
Accordingly, it is an object of the present invention to provide a feed additive capable of producing an animal food having a low cholesterol content while maintaining excellent meat quality of meat.
The object of the present invention can be achieved by a feed additive comprising a crustacean and a silicate mineral. The mixture ratio of the crust and the silicate mineral may be in the range of 7 to 3: 3 to 7, and most preferably 3: 7. The silicate mineral is characterized by a silicate content of at least 60% by weight.
The feed additive of the present invention has the effect of lowering the content of saturated fat and cholesterol while maintaining good meat quality of livestock.
Fig. 1 is a graph showing results of heat loss in Comparative Examples and Examples. Fig.
Fig. 2 is a graph showing the sensory tastes of Comparative Examples and Examples. Fig.
3 is a graph showing the sensory strengths of Comparative Examples and Examples.
4 is a graph showing the shear force of the comparative example and the embodiment.
5 is a graph showing the saturated fatty acid content of Comparative Examples and Examples.
6 is a graph showing the content of unsaturated fatty acids in Comparative Examples and Examples.
7 is a graph showing the content of monounsaturated fatty acids in Comparative Examples and Examples.
8 is a graph showing the content of polyunsaturated fatty acids in Comparative Examples and Examples.
9 is a graph showing the contents of omega-3 fatty acids in Comparative Examples and Examples.
10 is a graph showing the contents of omega-6 fatty acids in Comparative Examples and Examples.
11 is a graph showing the polyunsaturated: saturated fatty acid content ratio (Ps ratio) of Comparative Examples and Examples.
FIG. 12 shows the results of comparison between omega 6 of the comparative example and the example; Omega-3 fatty acid content.
The feed additives of the present invention include persimmon shells and silicate minerals. Dried persimmon can be obtained by drying and pulverizing a byproduct produced in the manufacture of dried persimmons, etc., and the silicate mineral may be any mineral containing silicates, such as silicon dioxide (SiO 2 ), and there is no particular limitation on the mineral. For example, the prepared silicate may be used, and clay, (pottery) pottery, feldspar, aluminum silicate, and mica containing silicate may be pulverized and used. The blend ratio of persimmon shells and silicate minerals can be in the range of 7: 3: 3 to 7, most preferably 3: 7. Silicate minerals having a silicate content of 60% by weight or more are used. These feed additives may be added to the feed and fed to the livestock, which is preferably, but not limited to, pigs. It is preferably added in an amount of 1 to 5% by weight of the total feed content. If it is less than 1% by weight, it is difficult to see effects such as lowering of cholesterol.
Hereinafter, the present invention will be described in more detail with reference to Examples.
Example
1. Materials and Methods
1) Place and period
The test was carried out at a pig farm located in Cheongli - myeon, Sangju, Gyeongbuk. The period was from June 1 to August 24, 2015 (about 3 months), and the meat was slaughtered for 1 month.
2) Test animals and housing conditions
The test pig varieties were the pigs produced by the three-way crossbreeding method, which was the artificially fertilized pig breeder in the mother line which is the cross-breed between Yorkshire and Land Race, which is the most domestically produced pig meat in Korea. Land race (L) x Yorkshire (Y) × Durok (D) ♂ = LYD (3-way hybrid pig), and the condition of pigs was the state-of-the-art facility which became automatic temperature device and ventilation facility. At this time, the size of the money room was 4.5m x 3.0 = 13.5m, and 10 of them were stocked in each room.
3) Treatment according to the addition of persimmon shells and minerals
Table 1 shows the test socket treatment.
The treatments were as follows: 100% commercial feed (100%), 99% compound feed, 0.3% persimmon feed, 0.7% mineral feed (Example 1), 98% Experiments were carried out on four treatments with 0.6% of feed + 1.4% of mineral feed (Example 2), 97% of compound feed + 0.9% of persimmon feed + 2.1% of mineral feed (Example 3). At this time, the crust husk was finely crushed and mixed well with the compound feed. The mineral crumb was basically small in size and did not require separate crushing. Therefore, the diets of the treatments were mixed with the compound feed, persimmon feed, and mineral feed by using a blender.
4) Test feed ingredient
(1) Compounding ratio and nutritional composition of compounded feed
During the test period, the compound feed was a typical finishing feed containing 45.5% corn, 26% wheat, and 15% soybean meal as feed for post-pork fattening. Table 2 shows the blending ratio of the compounded feed used in Table 2, and Table 3 shows the nutritional composition of the compounded feed.
Mixed feeds Nutrients were high in calories and lacked sufficient lysine to solve limited amino acid requirements and added methionine to increase the nutritional value of protein.
(2) Persimmon peel feed ingredients
The husks are rich in K, rich in vitamins A and C, and high in carbohydrate content. Table 4 shows the nutritional components of persimmon feeds.
(DM%)
(3) Mineral feed ingredients
The mineral feed used in the examples of the present invention is a typical mineral-type mineral feed composed of silicate (62.37%), manganese oxide (11.12%) and sodium oxide (6.20%). Table 5 shows the nutritional composition of mineral feed.
2. Experiment Items and Methods
1) Specification grade
(1) Feed intake
During the test, total concentrate, persimmon feed, and mineral feed intake were assessed
(2) Weight gain
The amount of weight gain is calculated by calculating the difference between the shipment weight and the weight at the start of the test
(3) Conductor weight
The weight of the conductor is obtained by slaughtering 10 pieces.
(4) Feed efficiency
Feed efficiency was calculated by dividing the total body weight gain by the total feed intake by each treatments. That is, feed efficiency = 1Kg Using the weight gain / feed intake formula
2) Conductivity
(1) Among the conductors
The conductors exclude heads, tails, baths, blood, leather, and internal organs in living bodies.
(2) Backing thickness and meat quality grade
The backfill thickness and the meat quality grade were used by the judge of grading by the grading criteria.
3) Nutritional characteristics of meat
Nutritional characteristics of meat were sampled after the slaughter on Aug. 26, and analyzed by Kyungpook National Univ. Twelve pigs were used in this experiment. Muscle acidity was measured at 45 minutes after slaughter, and sirloin roots were collected at 24 hours after cooling to analyze the meat quality, sensory characteristics, and fat characteristics.
The extraction of cholesterol from muscle tissue was performed by the Folch method. Five grams of muscle tissue was mixed with 50 ml of chloroform: methanol (2: 1, v / v), homogenized and sonicated for 1 hour. 1 filter paper, and the filtrate was dried under reduced pressure. To this, 5 ml of ethanol was added to dissolve the lipid and used as a sample for analysis. The total cholesterol was measured according to the enzyme method provided by Asan Pharmaceutical Co., Ltd. 0.02 ml of the prepared sample and 3.0 ml of the enzyme solution were mixed well and left at 37 캜 for 5 minutes. The absorbance was measured at a wavelength of 500 nm within 60 minutes by contrast with the reagent blank, and the standard solution was also used in the same manner. The absorbance of the sample was divided by the standard absorbance and multiplied by 300 to obtain the total cholesterol content. For HDL-cholesterol, 0.2 ml of the prepared sample and 0.2 ml of the separation reagent were mixed well, left at room temperature for 10 minutes, and then centrifuged at 3,000 rpm for 10 minutes. 0.1 ml of the supernatant and 3.0 ml of the enzyme solution were mixed well and allowed to stand at 37 ° C for 5 minutes. Absorbance was measured at a wavelength of 500 nm within 60 minutes by using a reagent blank as a control. The standard solution was also performed in the same manner, and the absorbance of the sample was divided by the absorbance of the standard solution and multiplied by 100 to obtain the amount of HDL-cholesterol.
LDL-cholesterol was calculated using the Friedwald formula.
Friedwald formula = (total cholesterol - HDL-cholesterol) - triglyceride / 5
3. Test results
1) Specification grade
The daily weight gain of Comparative Example 1 was 0.96 kg, while that of Example 1, Example 2 and Example 3 were 1.09, 0.98 and 1.05 kg, respectively, as compared with Comparative Example 1. In comparison with Comparative Example 1, 14%, 2%, and 3% of the body weight gain relative to the body weight gain index were increased, respectively. Table 6 shows the specifications.
(No treatment)
(1% mixed)
(2% blend)
(3% mixed)
Comparative Example 1 1 : control (control)
The feed efficiency of Examples 1 and 3 was much higher than that of Comparative Example 1. In terms of feed conversion ratio, Examples 1 and 3 are lower than those of Comparative Example 1, so that it can be determined that the feed is consumed less and the growth is good.
2) Conductivity
The backfill thickness of the conductor characteristics was thicker in the treatment groups (Examples 1, 2, and 3) than that of Comparative Example 1. And the range of backfill thickness difference was 0.4 ~ 3.9mm. In the meat quality grade, all of the treatments (Examples 1, 2, and 3) were higher than those of Comparative Example 1, and Example 3 was significantly higher than the others. Table 7 shows conductor results.
Comparative Example 1 1 : control (control)
(1, 2, 3, 4) 2 : 1+ grade (4 points), 1st grade (3 points), 2nd grade (2 points)
3) Nutritional characteristics of meat
(1) Water holding capacity
The heating loss was measured to analyze the water holding capacity of food. The results are shown in Fig. In the heat loss analysis, the control of Comparative Example 1 showed the highest value and the treatment amount was relatively low. The pork of Examples (1, 2, 3) was analyzed to be superior in heat loss compared to the control of the comparative example.
(2) Sensory Meat Color and Upper Intensity
To evaluate the sensory quality of fresh meat, sensory quality and phase intensity were analyzed (Figs. 2 and 3). In the case of the pork of the examples, the sensory score was 2-3 and the phase intensity was 2-3. Especially, in case of Example 3, no significant difference was observed but the sensory strength was high, which was higher than that of Berkshire pork excellent in marbling, and was higher than that of land race by about 1.0 or more.
(3) shear force
The shear force, which is an objective index of the year, is judged to be tender when the value is lower. The results are shown in Fig. In the case of Example 3, the lowest value was obtained and the year was analyzed to be very excellent. The results of the comparisons of meat quality characteristics are shown in Table 8.
Comparative Example 1: Control (control)
FFU: filter-paper fluid uptake
NPPC: National Pork Producer Council
WBS: warner-blatzler shear force
Initial pH: pH at 45 min
Final pH: pH at 24 hours
(4) fat and fat characteristics
Muscles are made up of about 100 chemical elements, most of which are oxygen, hydrogen, and carbon. Pork loin muscle showed the similar tendency. In the analysis of general composition, moisture content was the highest (7078%), crude protein (1822%), crude fat (0.510%) and ash (0.51.5). It is generally known that as the fat content increases, the ratio of protein to water decreases. The crude fat content analysis results showed higher contents in the treatment groups (Example 1, Example 2, Example 3) than the control (Comparative Example 1).
As a result of fatty acid composition analysis, fatty acid which occupied the highest ratio was analyzed as oleic acid (C18: 1 ω9) which is an unsaturated fatty acid. Example 3 (Example 3) showed a higher oleic acid composition than the control (C).
In addition, fatty acids occupying a high proportion were analyzed with saturated fatty acids such as palmitic acid (C16: 0) and stearic acid (C18: 0). This is consistent with the fatty acid composition ratio of the common pork loin. In general, saturated fatty acids have been known to adversely affect cardiovascular disease, but they have been reported to have different effects on the type of saturated fatty acids. For example, myristic acid is classified as a saturated fatty acid adversely affecting health due to an increase in LDL-cholesterol content, which adversely affects blood circulation. However, stearic acid, which has been analyzed in a large amount in pork (Example 3) Of saturated fatty acids. Another noteworthy point is that linoleic acid (C18: 2? 6), an essential fatty acid, was analyzed at a somewhat higher rate in Example 3. The results are shown in Table 9.
Comparative Example 1: Control (control)
The name of each fatty acid is shown in Table 10 below.
The health functional properties of fatty acid composition showed that the proportion of unsaturated fatty acids in all pork was higher than that of saturated fatty acids (FIGS. 5 and 6). Particularly, Example 3 was analyzed to have a significantly lower saturated fatty acid ratio and higher unsaturated fatty acid ratio than Comparative Example 1. This is because oleic acid (C18: 1), which is an unsaturated fatty acid, accounts for the highest percentage.
In the unsaturated fatty acid composition, the monounsaturated fatty acids were analyzed at a relatively higher ratio than the polyunsaturated fatty acids (FIGS. 7 and 8). Oleic acid (C18: 1), which is a monounsaturated fatty acid, is known to help prevent cardiovascular diseases such as atherosclerosis, and is rich in Example 3 and has an excellent fatty acid composition.
The polyunsaturated fatty acid composition of Example 3 was analyzed at a relatively high ratio compared to the other treatments and the control, and omega 3 and omega 6 fatty acids were also analyzed at a somewhat higher rate (FIGS. 9 and 10). The results of the indicators that reflect the health function of fatty acids are as follows.
First, the content of polyunsaturated fatty acid and the content of saturated fatty acid (P: S) were analyzed to examine the composition of fatty acids affecting cholesterol content in blood, and the results are shown in FIG. The P: S ratio is generally 0.40 or higher. Second, the analysis of the ratio of ω6 and ω3 fatty acids (ω6: ω3), which are more important in terms of thrombus formation, was found to be higher than the recommended value of less than 10 in all pork (Fig. 12). In general, increased ω6: ω3 is associated with increased risk of cardiovascular disease and cancer, especially with a significant thrombotic phenomenon (Enser, 2000). Pork is composed of ω6 fatty acids such as arachidonic acid and linolenic acid in polyunsaturated fatty acid composition, and ω6: ω3 ratio is higher than other species due to relatively weak development of ω3 fatty acid. Table 11 summarizes the fatty acid composition in a comprehensive manner.
Comparative Example 1 1 : control (control)
ab : Significant differences at 95% confidence level.
1 SFA (saturated fatty acid): saturated fatty acid
2 UFA (unsaturated fatty acid): unsaturated fatty acid
3 MUFA (mono-unsaturated fatty acid): monounsaturated fatty acid
4 PUFA (poly-unsaturated fatty acid): polyunsaturated fatty acid
5 ω3 (omega 3 fatty acid): C18: 3 ω3 + C20: 3 ω3 + C20: 5 ω3 + C22: 6 ω3.
6 ω6 (omega 6 fatty acid): C18: 2 ω6 + C18: 3 ω6 + C20: 2 ω6 + C20: 4 ω6.
7 P: S: ratio of unsaturated fatty acid to saturated fatty acid; (C18: 2? 6 + C18: 3? 6 + C18: 3? 3 + C20: 2? 6 + C20: 3? 3+ C20: 4? 6 + C20:? 3 + C22: 6? C16: 0 + C17: 0 + C18: 0)
8 ω6: ω3: ratio of omega-6 fatty acid to omega-3 fatty acid; (C18: 2 ω6 + C20: 4 ω6) / (C18: 3 ω3 + C20: 5 ω3 + C22: 6 ω3)
(5) Mineral component
The mineral contents of the treatments (Examples 1, 2 and 3) were higher than those of the control (Comparative Example 1), and 11%, 22% Example 3 showed an increased mineral content of 31%. The mineral content analysis result (mg / 100g) is shown in Table 12 below.
Comparative Example 1 1 : control (control)
(6) Cholesterol content
The cholesterol content of the treatments of the present invention was lower than that of the control of the comparative example, and the HDL content (cholesterol which is beneficial to health) was higher in the treatments than the control. And LDL (body - harmful cholesterol) was lower than that of the control. The cholesterol content (mg / 100 g) is shown in Table 13 below.
Comparative Example One One : control ( Control )
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150163278A KR101684457B1 (en) | 2015-11-20 | 2015-11-20 | Feed supplement for reducing cholesterol content which contains persimmon |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150163278A KR101684457B1 (en) | 2015-11-20 | 2015-11-20 | Feed supplement for reducing cholesterol content which contains persimmon |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101684457B1 true KR101684457B1 (en) | 2016-12-08 |
Family
ID=57576889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150163278A KR101684457B1 (en) | 2015-11-20 | 2015-11-20 | Feed supplement for reducing cholesterol content which contains persimmon |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101684457B1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100379075B1 (en) | 2002-03-07 | 2003-04-08 | Jinis Biopharmaceuticals Co | Method for producing low cholesterol animal food product and food product therefrom |
KR100385930B1 (en) | 2000-11-25 | 2003-06-02 | 상주축산업협동조합 | Supplementary feed composition for ruminant and method for feeding the same |
KR20120010033A (en) * | 2010-07-23 | 2012-02-02 | 이종두 | Feed additives comprising silicate mineral and feedstuff comprising the same |
KR20130049118A (en) * | 2011-11-03 | 2013-05-13 | 경상북도 (관련부서:경상북도축산기술연구소장) | Maeksumseok mixed with herbs livestock feed additives and manufacturing method thereof, mixed feed additives and method for breeding livestock |
KR20140119889A (en) * | 2013-03-28 | 2014-10-13 | (주)동양화학 | Animal feed additive composition with mushroom and red clay silicate, and process for preparation thereof |
-
2015
- 2015-11-20 KR KR1020150163278A patent/KR101684457B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100385930B1 (en) | 2000-11-25 | 2003-06-02 | 상주축산업협동조합 | Supplementary feed composition for ruminant and method for feeding the same |
KR100379075B1 (en) | 2002-03-07 | 2003-04-08 | Jinis Biopharmaceuticals Co | Method for producing low cholesterol animal food product and food product therefrom |
KR20120010033A (en) * | 2010-07-23 | 2012-02-02 | 이종두 | Feed additives comprising silicate mineral and feedstuff comprising the same |
KR20130049118A (en) * | 2011-11-03 | 2013-05-13 | 경상북도 (관련부서:경상북도축산기술연구소장) | Maeksumseok mixed with herbs livestock feed additives and manufacturing method thereof, mixed feed additives and method for breeding livestock |
KR20140119889A (en) * | 2013-03-28 | 2014-10-13 | (주)동양화학 | Animal feed additive composition with mushroom and red clay silicate, and process for preparation thereof |
Non-Patent Citations (1)
Title |
---|
"가축사양에 있어서 감 과피와 감 과피 탄닌 추출물의 이용", 제23차 한국가금학회 정기총회 및 학술발표회(2006.11.)* * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050266052A1 (en) | Animal feed supplement for the nutritional enrichment of animal produce | |
KR100934252B1 (en) | Its feed and an additive composition for poultry containing wild ginseng cultured root | |
JPS6398355A (en) | Feed for animal | |
CN105010856B (en) | The feed of content of polyunsaturated fatty acid in a kind of raising beef | |
US20090047378A1 (en) | Non marine or non algal sourced omega 3 feed/food supplement and process for stabilizing, enhancing the conversion efficiency, and enrichment of omega 3 fatty acids in livestock/humans and products therefrom | |
KR101909002B1 (en) | Pig feed composition including the Acorn, a breeding method using the same and pork obtained therefrom | |
US6316041B1 (en) | Poultry egg with beneficial health and nutritive values | |
KR101325566B1 (en) | Feed increasing CLA content in the goat milk and method for producing the same | |
KR100565013B1 (en) | Livestock feed to get nutrition egg and its Manufacturing method | |
JP5397727B2 (en) | Feeding method of livestock characterized by feeding specific feed | |
JPH0551271B2 (en) | ||
RU2497377C1 (en) | Chicken fodder | |
CN107455604A (en) | It is a kind of to be used to produce the feed addictive rich in omega-3 fatty acid egg | |
KR101684457B1 (en) | Feed supplement for reducing cholesterol content which contains persimmon | |
KR101684458B1 (en) | Methods for producing low cholesterol meat products comprising feeding persimmon | |
KR940007396B1 (en) | Omega-egg and omega-meat, method and assorted feed for producing them | |
Chilliard et al. | Trans and conjugated fatty acids in milk from cows and goats consuming pasture or receiving vegetable oils or seeds | |
KR101768762B1 (en) | Feed additive comprising fish oil, and poultry meat and egg containing high omega-3 content by feeding it, omega-3 supplement agent and omega-3 enriched food using the egg | |
KR100889655B1 (en) | Animal Feed Composition containing by-products obtained from purification process of the conjugated linoleic acid | |
Bielanski et al. | Use of linseed oil and antioxidant (vitamin E) in rabbit diets to improve dietetic traits of rabbit meat. | |
KR19990073078A (en) | Feed Compositions Containing Conjugated Linoleic Acids | |
Kumar et al. | Effect of feeding different level of Moringa oleifera leaf meal on growth performance, lipid profile and meat fatty acid composition of Vanaraja chicken in tropics | |
Kowalska | Effect of dietary supplementation with rapeseed and fish oil mixture and antioxidant on rabbit meat quality. | |
WO2010001387A2 (en) | Improved poultry meat products | |
Poudel | Comparing rapeseed fed chicken with ordinary soybean oil fed chicken |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |